Purchases and Sales Made in Q2 2022 in Protagenic Therapeutics, Inc.New (PTIX)
This table provides information about the institutional ownership of Protagenic Therapeutics, Inc.New (PTIX) during Q2 2022. The information is specifically focused on institutions that hold shares of Protagenic Therapeutics, Inc.new.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 05, 2022
Q2 2022
|
Concorde Asset Management, LLC
|
BUY
|
- |
12.4KNew |
$8.07K - $11.4K
|
12.4K
$5.96K
|
|
Aug 10, 2022
Q2 2022
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
6K+ 118.69% |
$3.9K - $5.52K
|
11.1K
$5.31K
|
|
Aug 15, 2022
Q2 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
1.72K+ 39.54% |
$1.12K - $1.58K
|
6.06K
$2.91K
|
|
Aug 12, 2022
Q2 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
8+ 9.41% |
$5.2 - $7.36
|
93
$44.6
|
|
Jul 28, 2022
Q2 2022
|
Cwm, LLC
|
BUY
|
- |
3New |
$1.95 - $2.76
|
3
$1.44
|
|
Aug 15, 2022
Q2 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
1New |
$0.65 - $0.92
|
1
$0.48
|
|
Aug 09, 2022
Q2 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Aug 15, 2022
Q2 2022
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-1Closed |
$0.65 - $0.92
|
0
$0
|
|
Aug 10, 2022
Q2 2022
|
Citigroup Inc
|
SELL
|
- |
-250Closed |
$163 - $230
|
0
$0
|
|
Aug 10, 2022
Q2 2022
|
Ubs Group Ag
|
SELL
|
- |
-1.37K- 57.38% |
$892 - $1.26K
|
1.02K
$490
|
|
Aug 09, 2022
Q2 2022
|
Virtu Financial LLC
New York, NY |
SELL
|
- |
-13KClosed |
$8.48K - $12K
|
0
$0
|
|
Aug 16, 2022
Q2 2022
|
First Republic Investment Management, Inc.
San Francisco, CA |
SELL
|
- |
-17.5KClosed |
$11.4K - $16.1K
|
0
$0
|
|
Aug 15, 2022
Q2 2022
|
Oracle Investment Management Inc
Greenwich, CT |
SELL
|
- |
-20KClosed |
$13K - $18.4K
|
0
$0
|
|
Aug 12, 2022
Q2 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-52K- 50.88% |
$33.8K - $47.8K
|
50.2K
$24.1K
|